Literature DB >> 16301679

Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: role of arginine-glycine-aspartic acid (RGD)- and non-RGD-binding integrins.

Myew-Ling Toh1, Saw-See Hong, Fons van de Loo, Laure Franqueville, Leif Lindholm, Wim van den Berg, Pierre Boulanger, Pierre Miossec.   

Abstract

Rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) do not express the coxsackie-adenovirus (Ad) receptor and are poorly permissive to Ad serotype 5 (Ad5). Genetically modified, coxsackie-Ad receptor-independent Ad5 vectors were studied for gene delivery in human RA FLS and synovium explants and murine collagen-induced arthritis. Short-fiber Ad5 vectors with seven fiber shaft repeats Ad5GFP-R7-knob, Ad5GFP-R7-arginine-glycine-aspartic acid (RGD) (RGD-liganded), and Ad5GFPDeltaknob (knob-deleted) were compared with Ad5GFP-FiWT, a conventional wild-type (WT) Ad5 vector. Gene transfer by Ad5GFP-R7-knob and Ad5GFP-R7-RGD was 40- to 50-fold and 25-fold higher, respectively, than Ad5GFP-FiWT in FLS. Ad5GFPDeltaknob was more efficacious than its knob-bearing version Ad5GFP-R7-knob in FLS transduction. Virus attachment and entry required RGD- and LDV-binding integrins including alpha(v), alpha(v)beta3, a(v)beta5, and beta1. Ad5GFP-R7-knob infection of FLS was partially neutralized by synovial fluid (SF), but remained 30- to 40-fold higher than Ad5GFP-FiWT in the presence of SF. Ad5GFPDeltaknob was partially neutralized by SF at low virus input, but escaped viral neutralization by SF at higher virus input. Gene transfer to human synovium ex vivo explants and murine collagen-induced arthritis in vivo was also more efficient with short fiber-modified vectors (with and without the knob domain) than Ad5GFPFiWT. Gene transfer by short fiber-modified vectors was enhanced by inflammatory cytokines in vitro and in the presence of inflammation in murine synovium in vivo. Our data indicated that the highly efficient gene delivery RA was mediated by RGD- and non-RGD-binding integrins and enhanced by inflammation. Short fiber modifications with knob ablation may be a strategy to enhance gene delivery, reducing vector dose and vector-induced inflammation and toxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301679     DOI: 10.4049/jimmunol.175.11.7687

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Human ESC vs. iPSC-pros and cons.

Authors:  Jane J Pappas; Phillip C Yang
Journal:  J Cardiovasc Transl Res       Date:  2008-05-30       Impact factor: 4.132

Review 2.  Gene therapy works in animal models of rheumatoid arthritis...so what!

Authors:  Fons A J van de Loo; Jeroen Geurts; Wim B van den Berg
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

3.  Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression.

Authors:  Myew-Ling Toh; Gaelle Gonzales; Marije I Koenders; Anne Tournadre; David Boyle; Erik Lubberts; Yuan Zhou; Gary S Firestein; Wim B van den Berg; Pierre Miossec
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

4.  Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped baculovirus.

Authors:  Ophélia Granio; Marine Porcherot; Stéphanie Corjon; Kuntida Kitidee; Petra Henning; Assia Eljaafari; Andrea Cimarelli; Leif Lindholm; Pierre Miossec; Pierre Boulanger; Saw-See Hong
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

5.  Essential role for the lectin pathway in collagen antibody-induced arthritis revealed through use of adenovirus programming complement inhibitor MAp44 expression.

Authors:  Nirmal K Banda; Gaurav Mehta; Troels R Kjaer; Minoru Takahashi; Jerome Schaack; Thomas E Morrison; Steffen Thiel; William P Arend; V Michael Holers
Journal:  J Immunol       Date:  2014-07-28       Impact factor: 5.422

6.  PUMA gene delivery to synoviocytes reduces inflammation and degeneration of arthritic joints.

Authors:  Saw-See Hong; Hubert Marotte; Guillaume Courbon; Gary S Firestein; Pierre Boulanger; Pierre Miossec
Journal:  Nat Commun       Date:  2017-07-27       Impact factor: 14.919

7.  Methotrexate-loaded multifunctional nanoparticles with near-infrared irradiation for the treatment of rheumatoid arthritis.

Authors:  You-Jung Ha; Sun-Mi Lee; Chin Hee Mun; Hyung Joon Kim; Yonghee Bae; Ji-Hee Lim; Kyu-Hyung Park; Soo-Kon Lee; Kyung-Hwa Yoo; Yong-Beom Park
Journal:  Arthritis Res Ther       Date:  2020-06-18       Impact factor: 5.156

8.  Anti-Rheumatic Properties of Gentiopicroside Are Associated With Suppression of ROS-NF-κB-NLRP3 Axis in Fibroblast-Like Synoviocytes and NF-κB Pathway in Adjuvant-Induced Arthritis.

Authors:  Meiling Wang; Hongyan Li; Yanfang Wang; Yanfei Hao; Yanan Huang; Xinlin Wang; Yongying Lu; Yuan Du; Fenghua Fu; Wenyu Xin; Leiming Zhang
Journal:  Front Pharmacol       Date:  2020-05-04       Impact factor: 5.810

Review 9.  Gene therapy of the rheumatic diseases: 1998 to 2008.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Arthritis Res Ther       Date:  2009-01-30       Impact factor: 5.156

Review 10.  Gene therapy for arthritis.

Authors:  Russell S Traister; Raphael Hirsch
Journal:  Mod Rheumatol       Date:  2008-01-05       Impact factor: 3.023

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.